Midpregnancy levels of angiogenic markers in relation to maternal characteristics

American Journal of Obstetrics and Gynecology

Volumn 204, Issue 3, 2011, Pages 244.e1-244.e12

  Mijal, Renée S ^a   Holzman, Claudia B ^a   Rana, Sarosh ^c   Karumanchi, S Ananth ^c   Wang, Jianling ^a   Sikorskii, Alla ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

angiogenic factor; placental growth factor; preeclampsia; soluble endoglin; soluble Fms like tyrosine kinase 1

Indexed keywords

ANGIOGENIC PROTEIN; PLACENTAL GROWTH FACTOR; SOLUBLE ENDOGLIN; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; BODY MASS; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SMOKING; MULTIPARA; PREMATURE LABOR; PRIMIPARA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE; SECOND TRIMESTER PREGNANCY; SMOKING CESSATION;

EID: 79952312779     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.10.001     Document Type: Conference Paper

References (52)

1. R. Romero, J.K. Nien, and J. Espinoza A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate J Matern Fetal Neonatal Med 21 2008 9 23
2. A. Wang, S. Rana, and S.A. Karumanchi Preeclampsia: the role of angiogenic factors in its pathogenesis Physiology (Bethesda) 24 2009 147 158
3. C. Signore, J.L. Mills, and C. Qian Circulating soluble endoglin and placental abruption Prenat Diagn 28 2008 852 858
4. C.V. Ananth, and A.M. Vintzileos Medically indicated preterm birth: recognizing the importance of the problem Clin Perinatol 35 2008 53 67 (Pubitemid 351232001)
5. R.J. Levine, S.E. Maynard, and C. Qian Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683 (Pubitemid 38364626)
6. R.J. Levine, C. Lam, and C. Qian Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 2006 992 1005 (Pubitemid 44343543)
7. G.C.S. Smith, J.A. Crossley, and D.A. Aitken Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth and stillbirth Obstet Gynecol 109 2007 1316 1324 (Pubitemid 46869870)
8. T. Chaiworapongsa, R. Romero, and A. Tarca A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study J Matern Fetal Neonatal Med 22 2009 1122 1139
9. A.M. Holston, C. Qian, K.F. Yu, F.H. Epstein, A. Karumanchi, and R.J. Levine Circulating angiogenic factors in gestational proteinuria without hypertension Am J Obstet Gynecol 200 2009 10
10. J. Espinoza, T. Chaiworapongsa, and R. Romero Unexplained fetal death: another anti-angiogenic state J Matern Fetal Neonatal Med 20 2007 495 507 (Pubitemid 47221572)
11. M. Autiero, A. Luttun, M. Tjwa, and P. Carmeliet Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders J Thromb Haemost 1 2003 1356 1370
12. C.J. Lockwood, P. Toti, and F. Arcuri Thrombin regulates soluble Fms-like tyrosine kinase-1 (sflt-1) expression in first trimester decidua Am J Pathol 170 2007 1398 1405 (Pubitemid 47339346)
13. A. Rajakumar, H.M. Michael, and P.A. Rajakumar Extra-placental expression of vascular endothelial growth factor receptor-1, (flt-1) and soluble flt-1 (sfit-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women Placenta 26 2005 563 573 (Pubitemid 40916309)
14. R. Demir, Y. Seval, and B. Huppertz Vasculogenesis and angiogenesis in the early human placenta Acta Histochemica 109 2007 257 265 (Pubitemid 46962081)
15. J. Espinoza, J.E. Uckele, R.A. Starr, D.E. Seubert, A.F. Espinoza, and S.M. Berry Angiogenic imbalances: the obstetric perspective Am J Obstet Gynecol 203 2010 17.e1 17.e8
16. R. Thadhani, W.P. Mutter, and M. Wolf First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2004 770 775 (Pubitemid 38269892)
17. S. Venkatesha, M. Toporsian, and C. Lam Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 2006 642 649 (Pubitemid 43865232)
18. L.J. Vatten, A. Eskild, T.I.L. Nilsen, S. Jeansson, P.A. Jenum, and A.C. Staff Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia Am J Obstet Gynecol 196 2007 239.e1 239.e6
19. M.D. Lindheimer, and R. Romero Emerging roles of antiangiogenic and angiogenic proteins in pathogenesis and prediction of preeclampsia Hypertension 50 2007 35 36 (Pubitemid 46986005)
20. A.C. Staff, N.K. Harsem, K. Braekke, M. Hyer, R.N. Hoover, and R. Troisi Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies Eur J Obstet Gynecol Reprod Biol 143 2009 29 33
21. L.C.Y. Poon, N.A. Kametas, N. Maiz, R. Akolekar, and K.H. Nicolaides First-trimester prediction of hypertensive disorders in pregnancy Hypertension 53 2009 812 818
22. R.W. Powers, J.M. Roberts, and K.M. Cooper Maternal serum soluble Fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia Am J Obstet Gynecol 193 2005 185 191 (Pubitemid 40991843)
23. S.E. Maynard, J.Y. Min, and J. Merchan Excess placental soluble Fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658 (Pubitemid 36278583)
24. M. Wolf, A. Shah, and C. Lam Circulating levels of the antiangiogenic marker sflt-1 are increased in first versus second pregnancies Am J Obstet Gynecol 193 2005 16 22 (Pubitemid 40991821)
25. A. Jeyabalan, S. McGonigal, C. Gilmour, C.A. Hubel, and A. Rajakumar Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia Placenta 29 2008 555 563
26. R. Akolekar, E. Zaragoza, L.C.Y. Poon, S. Pepes, and K.H. Nicolaides Maternal serum placental growth factor at 11+0 to 13+6 weeks of gestation in the prediction of preeclampsia Ultrasound Obstet Gynecol 32 2008 732 739
27. J.P. Kusanovic, R. Romero, and T. Chaiworapongsa A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia J Matern Fetal Neonatal Med 22 2009 1021 1038
28. I. Vogel, P. Thorsen, A. Curry, P. Sandager, and N. Uldbjerg Biomarkers for the prediction of preterm delivery Acta Obstet Gynecol Scand 84 2005 516 525 (Pubitemid 40756419)
29. M.P.R. Hamilton, H.I. Abdalla, and C.R. Whitfield Significance of raised maternal serum alpha-fetoprotein in singleton pregnancies with normally formed fetuses Obstet Gynecol 65 1985 465 470 (Pubitemid 15099140)
30. J. Xu, C. Holzman, C. Arvidson, H. Chung, and A. Goepfert Midpregnancy vaginal fluid defensins, bacterial vaginosis and risk of preterm delivery Obstet Gynecol 112 2008 524 531
31. G.R. Alexander, J.H. Himes, R.B. Kaufman, J. Mor, and M. Kogan A United States national reference for fetal growth Obstet Gynecol 87 1996 163 168 (Pubitemid 26033124)
32. Division of Nutrition, Physical Activity and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention About BMI for Adults, 2009 (vol 2010) http://www.cdc.gov/ healthyweight/assessing/bmi/adult-bmi/index.html Accessed June 7, 2010
33. B. Sibai, G. Dekker, and M. Kupferminc Pre-eclampsia Lancet 365 2005 785 799 (Pubitemid 40311367)
34. M. Widmer, J. Villar, A. Benigni, A. Conde-Agudelo, S.A. Karumanchi, and M. Lindheimer Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review Obstet Gynecol 109 2007 168 180 (Pubitemid 46035522)
35. L. Wa Law, D.S. Sahota, L. Wai Chan, M. Chen, T. Kin Lau, and T.Y. Leung Effect of long-term storage on placental growth factor and Fms-like tyrosine kinase 1 measurements in samples from pregnant women J Matern Fetal Neonatal Med 23 2010 1475 1480
36. D. Kim Waller, L.S. Lustig, G.C. Cunningham, L.B. Feuchtbaum, and E.B. Hook The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications Obstet Gynecol 88 1996 816 822 (Pubitemid 26360825)
37. M.N. Louis, E.P. Glenn, A.L. David, J.K. George, and E.H. James Refinements in managing maternal weight adjustment for interpreting prenatal screening results Prenat Diagn 16 1996 1115 1119
38. Y. Chen, C. Holzman, H. Chung, P. Senagore, N.M. Talge, and T. Siler-Khodr Levels of maternal serum corticotrophin-releasing hormone (CRH) at midpregnancy in relation to maternal characteristics Psychoneuroendocrinology 35 2010 820 832
39. J.M. Faupel-Badger, C.-C. Hsieh, R. Troisi, P. Lagiou, and N. Potischman Plasma volume expansion in pregnancy: implications for biomarkers in population studies Cancer Epidemiol Biomarkers Prev 16 2007 1720 1723 (Pubitemid 47450499)
40. S.P. Salas, G. Marshall, B. Gutierrez, and P. Rosso Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction Hypertension 47 2006 203 208 (Pubitemid 43189764)
41. R.B. Ness, and B.M. Sibai Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia Am J Obstet Gynecol 195 2006 40 49 (Pubitemid 43927490)
42. R.B. Ness, J. Zhang, D. Bass, and M.A. Klebanoff Interactions between smoking and weight in pregnancies complicated by preeclampsia and small-for-gestational-age birth Am J Epidemiol 168 2008 427 433
43. A. Conde-Agudelo, F. Althabe, J.M. Belizan, and A.C. Kafury-Goeta Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review Am J Obstet Gynecol 181 1999 1026 1035 (Pubitemid 29503633)
44. A. Jeyabalan, R.W. Powers, A.R. Durica, G.F. Harger, J.M. Roberts, and R.B. Ness Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia Am J Hypertens 21 2008 943 947
45. R. Levine, C. Qian, K. Yu, B. Sibai, and A. Karumanchi Circulating angiogenic factors in smokers and non-smokers during normotensive pregnancy Am J Obstet Gynecol 195 2006 S37
46. R.J. Levine, C. Qian, S.E. Maynard, K.F. Yu, F.H. Epstein, and S.A. Karumanchi Serum sflt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women Am J Obstet Gynecol 194 2006 1034 1041
47. S.A. Karumanchi, and R.J. Levine How does smoking reduce the risk of preeclampsia? Hypertension 55 2010 1100 1101
48. L.J. England, A. Grauman, and C. Qian Misclassification of maternal smoking status and its effects on an epidemiologic study of pregnancy outcomes Nicotine Tob Res 9 2007 1005 1013 (Pubitemid 350018184)
49. A.-K. Wikstrom, O. Stephansson, and S. Cnattingius Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff Hypertension 55 2010 1254 1259
50. B. Eskenazi, L. Fenster, and S. Sidney A multivariate analysis of risk factors for preeclampsia JAMA 266 1991 237 241
51. S. Rana, S.A. Karumanchi, and R.J. Levine Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia Hypertension 50 2007 137 142 (Pubitemid 46986022)
52. O. Erez, R. Romero, and J. Espinoza The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age J Matern Fetal Neonatal Med 21 2008 279 287 (Pubitemid 351652513)